Dr Mark Beggs - Chief Executive Dr Mark Beggs - Chief Executive

Dr Mark Beggs - Chief Executive

Mark joined UK Biocentre in July 2016 as Managing Director becoming Chief Executive in 2017. Mark holds a PhD in Clinical Biochemistry and a BA in Biochemistry both from Oxford University.

Prior to UK Biocentre, he developed significant experience in managing academic/industry collaborations as Chief Executive of Stratified Medicine Scotland, a nationally co-ordinated genomic medicine initiative, and previously as Programme Manager of Pfizer’s (former Wyeth) Translational Medicine Research Collaboration programme.
Prior to this, Mark was Head of Consulting at TAP Biosystems (as The Automation Partnership) in Cambridgeshire UK for eight years where he led a consulting team in delivering major change programmes for clients within Pharma Discovery and Biological production with particular focus on the application of manufacturing consultancy techniques in a Pharma Discovery environment.

Mark has an additional ten year’s direct experience in early stage Pharma Discovery roles, having worked variously for GSK (as Glaxo) in North Carolina USA, Astra Zeneca (as Zeneca) in Alderley Park, UK and J&J in Beerse, Belgium where he was Director of HTS. In these roles he developed significant experience in the design and deployment of automated systems for life science applications and in process scale-up.

Back to management team